Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission

Robert C Mould1, Jacob P van Vloten1, Amanda W K AuYeung1

  • 1Department of PathobiologyOntario Veterinary College, University of Guelph, Guelph, Ontario, Canada.

Endocrine-Related Cancer
|September 16, 2017
PubMed

Insights

Thyroid cancer incidence is rising, with poor outcomes for advanced disease. This review explores cancer immunotherapy as a novel treatment by examining thyroid cancer

Area of Science:

  • Oncology
  • Immunology
  • Endocrinology

Background:

  • Thyroid cancer incidence is increasing globally.
  • Differentiated thyroid cancers have high survival rates, but undifferentiated, recurrent, or metastatic disease have poor outcomes.
  • Novel therapeutic strategies are needed for advanced thyroid cancers.

Purpose of the Study:

  • To review the immunological landscape of thyroid cancers.
  • To discuss the modulation of thyroid cancer immunity.
  • To explore the potential of cancer immunotherapy in thyroid cancer treatment.

Main Methods:

  • Literature review of thyroid cancer immunology and immunotherapy.
  • Analysis of immunological consequences of conventional therapies.
  • Examination of hormonal modulation of the immune system in thyroid cancer.

Main Results:

  • The thyroid cancer microenvironment is immunologically active.
  • Conventional therapies can have unexpected immunological effects.
  • Hormonal factors uniquely influence thyroid cancer immunity.

Conclusions:

  • Cancer immunotherapy holds promise for thyroid cancer, especially for advanced disease.
  • Understanding thyroid cancer's unique immunological features is crucial for effective treatment.
  • Integration of immunotherapy with standard care and further research are high priorities.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K